← 홈

자가면역·염증성 · TNF-α

156개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 156개
AntibodystaleJanssenPhase 3

Infliximab precision dosing (Infliximab precision dosing)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

IIFX + AZA (Infliximab with azathioprine, Infliximab with azathioprine (IIFX + AZA))

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

adalimumab (Humira, Infliximab, adalimumab, certolizumab pegol)

Inflammatory Bowel Disease; Crohn's Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Infliximab, methylprednisolone, methotrexate (Infliximab, methylprednisolone, methotrexate)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

Infliximab-Dyyb (Infliximab-Dyyb)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

Infliximab-Innovator (Infliximab-Innovator)

Colitis, Ulcerative; Crohn's Disease · Colitis, Ulcerative

#ColitisUlcerative#Antibody#Approved#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

adalimumab (Humira, Infliximab: Adalimumab; Etanercept;)

Rheumatoid Arthritis; Inflammatory Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 2

Infliximab; Gemcitabine (Infliximab; Gemcitabine)

Cachexia; Pancreatic Neoplasms · Cachexia

#Cachexia#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

Infliximab; observational study (Infliximab; observational study)

Spondylitis, Ankylosing; Arthritis, Rheumatoid · Spondylitis, Ankylosing

#SpondylitisAnkylosing#Antibody#Preclinical#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Innovator infliximab (Innovator infliximab)

Rheumatoid Arthritis; Spondyloarthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

Intraarticular injection of infliximab (Intraarticular injection of infliximab)

Arthritis · Arthritis

#Arthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleUniversité Catholique de LouvainApproved

Methotrexate + Infliximab (Methotrexate + Infliximab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbVie (prior sponsor, Abbott)Phase 2

adalimumab (Humira, New formulation adalimumab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
효능 ORR 98.4%임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, OLE BSA Adalimumab +/- MTX)

Arthritis, Juvenile Idiopathic · Arthritis, Juvenile Idiopathic

#ArthritisJuvenileIdiopathic#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, OLE FD Adalimumab +/- MTX)

Arthritis, Juvenile Idiopathic · Arthritis, Juvenile Idiopathic

#ArthritisJuvenileIdiopathic#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleAbbottPhase 3

adalimumab (Humira, Open-labelAdalimumabRescue)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

PRECISION dosing Infliximab (PRECISION dosing Infliximab)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Palmitoleic Acid + Infliximab (Palmitoleic Acid + Infliximab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleLoyola UniversityPhase 2

infliximab (Remicaide, Remicaide (infliximab))

Toxic Epidermal Necrolysis · Toxic Epidermal Necrolysis

#ToxicEpidermalNecrolysis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleSamsung Bioepis Co., Ltd.Phase 3

proposed biosimilar to infliximab (SB2, SB2 (proposed biosimilar to infliximab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE

6 / 8 페이지

← 이전다음 →